Zhang Ping Ye

Zhang Ping Ye is a declared insider of Peijia Medical Ltd. - B (chief executive), with filings sourced from HKEX. We count 35 filings; the first trade dates from 15 May 2020 and the latest from 3 June 2026.

In open-market terms, that means 26 purchases worth €32.7M on one side and 7 sales worth €1.7M on the other. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 9 purchases and no sales on the market.

In size, the median ticket on the buying side is €110k. As a share of market capitalisation, the median purchase stands at 0.068%, based on 9 purchases. 25 out of 25 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 17 purchases old enough to measure, the stock rose over the following 90 days in 35% of cases; the median change was -1.0%. These figures describe past trades and do not predict future prices.

The record was last updated on 8 June 2026 with an open-market purchase (€22k) in Peijia Medical Ltd. - B. Filings reach the HKEX feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from HKEX. Past trades are no guide to future returns.